TANG CAPITAL MANAGEMENT LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1232621
SAN DIEGO, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$92,065,158
+$18,202,649 QoQ
Shares Held
4,573,530
0.0% QoQ
Ownership
8.59%
of shares outstanding
% of Portfolio
4.68%
of 13F equity value
Holder Rank
#4
of 182 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TANG CAPITAL MANAGEMENT LLC holds $1,657,542,525 across 43 Biotechnology names. KALV ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
12,229,500 | $181,241,190 | |
| 2 | CELC |
Celcuity Inc.
|
1,050,000 | $119,847,000 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,236,027 | $114,184,174 | |
| 4 | LKFT |
Lakefront Biotherapeutics NV
|
3,785,991 | $113,579,730 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
3,399,900 | $103,356,960 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,500,000 | $102,195,000 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
1,892,200 | $95,442,568 | |
| 8 | KALV |
KalVista Pharmaceuticals, Inc.
This page
|
4,573,530 | $92,065,158 |
All Filings in KALV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,065,158 | 4,573,530 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $73,862,509 | 4,573,530 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $61,409,099 | 5,041,798 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $55,867,026 | 4,941,798 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $57,028,348 | 4,941,798 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $41,450,884 | 4,893,847 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $50,043,514 | 4,321,547 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $49,697,805 | 4,218,829 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $48,926,591 | 4,125,345 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $42,144,226 | 3,440,345 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $33,130,522 | 3,440,345 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $23,862,537 | 2,651,393 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $20,839,948 | 2,651,393 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $21,607,974 | 3,196,446 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $26,118,000 | 1,800,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $17,712,000 | 1,800,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $9,555,485 | 648,269 | Shares | Other | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||